http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : Davod Javanmard (검색결과 2 건)
- 무료
- 기관 내 무료
- 유료
-
Human parvovirus B19 and parvovirus 4 among Iranian patients with hemophilia
Davod Javanmard,Masood Ziaee,Hadi Ghaffari,Mohammad Hasan Namaei,Ahmad Tavakoli,Hamidreza Mollaei,Mohsen Moghoofei,Helya Sadat Mortazavi,Seyed Hamidreza Monavari 대한혈액학회 2017 Blood Research Vol.51 No.4
Background: Human parvovirus B19 (B19V) is one of the smallest DNA viruses and shows great resist-ance to most disinfectants. Therefore, it is one of the common contaminant pathogens present in blood and plasma products. Parvovirus 4 (PARV4) is a newly identified parvovi-rus, which is also prevalent in parenteral transmission. In this study, we aimed to evaluate the prevalence of B19V and PARV4 DNA among patients with hemophilia in Birjand County in eastern Iran. Methods: This was a cross-sectional epidemiological study comprising nearly all people with hemo-philia in this region. Whole blood samples were taken after patient registration and sent for plasma isolation. After nucleic acid extraction, B19V was detected with real-time poly-merase chain reaction, PARV4 DNA was then detected using sensitive semi-nested PCR. Results: In total, there were 86 patients with hemophilia, with mean age 28.5±1.5 years. Of these, 90.7% were men and 9.3% women; 84.9% had hemophilia A and 7.0% had hemophilia B. We found 11 patients (12.8%) were positive for B19V DNA and 8 were positive (9.3%) for PARV4 DNA. The prevalence of B19V was higher in middle-aged groups rather than younger people, whereas PARV4 infection was more common in younger patients (P<0.05). Conclusion: There was a high prevalence of B19V and PARV4 infection in this high-risk group of pa-tients with hemophilia. Due to the clinical significance of the B19 virus, imposing more precautionary measures for serum and blood products is recommended.
-
Human parvovirus B19 and parvovirus 4 among Iranian patients with hemophilia
Davod Javanmard,Masood Ziaee,Hadi Ghaffari,Mohammad Hasan Namaei,Ahmad Tavakoli,Hamidreza Mollaei,Mohsen Moghoofei,Helya Sadat Mortazavi,Seyed Hamidreza Monavari 대한혈액학회 2017 Blood Research Vol.52 No.4
Background: Human parvovirus B19 (B19V) is one of the smallest DNA viruses and shows great resist-ance to most disinfectants. Therefore, it is one of the common contaminant pathogens present in blood and plasma products. Parvovirus 4 (PARV4) is a newly identified parvovi-rus, which is also prevalent in parenteral transmission. In this study, we aimed to evaluate the prevalence of B19V and PARV4 DNA among patients with hemophilia in Birjand County in eastern Iran. Methods: This was a cross-sectional epidemiological study comprising nearly all people with hemo-philia in this region. Whole blood samples were taken after patient registration and sent for plasma isolation. After nucleic acid extraction, B19V was detected with real-time poly-merase chain reaction, PARV4 DNA was then detected using sensitive semi-nested PCR. Results: In total, there were 86 patients with hemophilia, with mean age 28.5±1.5 years. Of these, 90.7% were men and 9.3% women; 84.9% had hemophilia A and 7.0% had hemophilia B. We found 11 patients (12.8%) were positive for B19V DNA and 8 were positive (9.3%) for PARV4 DNA. The prevalence of B19V was higher in middle-aged groups rather than younger people, whereas PARV4 infection was more common in younger patients (P<0.05). Conclusion: There was a high prevalence of B19V and PARV4 infection in this high-risk group of pa-tients with hemophilia. Due to the clinical significance of the B19 virus, imposing more precautionary measures for serum and blood products is recommended.
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
